|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.KR |
First Approval Date17 Aug 2011 |
|
MechanismcGMP-PDE inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism5α-reductase inhibitors [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shinpoong Pharmaceutical Co., Ltd. ESOA
0 Patents (Medical) associated with Shinpoong Pharmaceutical Co., Ltd. ESOA
100 Deals associated with Shinpoong Pharmaceutical Co., Ltd. ESOA
100 Translational Medicine associated with Shinpoong Pharmaceutical Co., Ltd. ESOA